Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Surrozen Publishes Study In 'eLife' Highlihgitng Potential To Enhance Wnt-Signal Activation In Targeted SWEETS Bispecific Antibodies

Author: Benzinga Newsdesk | June 12, 2024 08:32am

Targeted protein degradation (TPD*) technologies have demonstrated the potential to produce novel treatment approaches

 

Surrozen's current SWEETS bispecific antibodies are unique TPD technologies

Results demonstrated that the two new ASGR-targeted SWEETS bispecific antibodies enhanced Wnt-signal activation through the unique TPD platform

Posted In: SRZN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist